PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 22, 2026Transplant Infectious Disease0 citationsOpen Access

Performance of the BioFire FilmArray Pneumonia Panel Plus Compared to Standard Microbiology in Lung Transplant Donor and Recipient Samples: A Prospective Cohort Study

View Full Paper
ALAndrea LombardiGRGiulia RenisiLRLorenzo Rosso

Key Points

  • This research aims to compare the BioFire FilmArray Pneumonia Panel Plus with standard microbiology for pathogen detection in lung transplant donors and recipients.
  • Conducted a prospective cohort study with 53 donor-recipient pairs.
  • Analyzed bronchoalveolar lavage samples from donors at procurement and from recipients 72 hours post-transplant.
  • Assessed concordance for bacterial species and antimicrobial resistance genes between the BioFire panel and standard care.
  • BioFire panel identified pathogens in 67.9% of donor samples vs. 63.5% by standard care, with faster results (221 min vs. 5.3 days).
  • Substantial concordance for bacterial species in donor samples (Cohen's κ = 0.654).
  • In recipient samples, pathogens were detected in 61.5% with BioFire vs. 47.2% with standard care, but concordance was moderate (κ = 0.365).
  • BioFire panel identified additional resistance genes not found by standard care, and distinct viruses not detected by traditional methods.

Abstract

ABSTRACT Background Lung transplantation (LuTx) is hampered by infectious risks. Perioperative antibiotic prophylaxis (PAP) is widely used; however, real‐time adjustment is hindered by the timing of standard microbiology. Syndromic molecular panels offer rapid results, yet their integration into PAP strategies remains unclear. Methods We conducted a prospective cohort study comparing the BioFire FilmArray Pneumonia Panel Plus (PN plus ) with standard of care (SOC) on bronchoalveolar lavage (BAL) samples obtained from donors at procurement and from recipients 72 h after LuTx. Concordance between PN plus and SOC was assessed for bacterial species and antimicrobial resistance genes. Results Fifty‐three donor‐recipient pairs were analyzed. In donor BAL, PN plus identified at least one pathogen in 67.9% (36/53) of cases versus 63.5% (33/53) by SOC, with a markedly shorter time to result (221 min vs. 5.3 days). Concordance between PN plus and SOC for bacterial species was substantial (Cohen's κ = 0.654), particularly for Staphylococcus aureus (Cohen's κ = 0.689), Streptococcus pneumoniae (Cohen's κ = 0.658), and Pseudomonas aeruginosa (Cohen's κ = 0.731). In recipient BAL, PN plus detected pathogens in 61.5% (32/53) compared to 47.2% (25/53) with SOC, but overall concordance was only moderate ( κ = 0.365). Resistance gene concordance was minimal, with PN plus often identifying additional determinants not confirmed by SOC. Viruses were detected exclusively by PN plus , while fungi were identified only by SOC. Conclusion PN plus provides rapid, clinically relevant pathogen detection in LuTx, showing substantial agreement with SOC in donor samples and offering potential to support PAP adjustment. In early post‐transplant recipient BAL, interpretation requires caution, and SOC remains indispensable, particularly for detecting fungi and confirming phenotypic resistance. image

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lombardi et al. (2026) studied this question.

synapsesocial.com/papers/699a9e2d482488d673cd4ab1https://doi.org/10.1111/tid.70186
Ask AI
Helpful
Bookmark
Share
View Full Paper